Deva Holding AS (DEVA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Deva Holding AS (DEVA) has a cash flow conversion efficiency ratio of 0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL1.53 Billion ≈ $34.34 Million USD) by net assets (TL26.48 Billion ≈ $593.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Deva Holding AS - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Deva Holding AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Deva Holding AS balance sheet liabilities for a breakdown of total debt and financial obligations.
Deva Holding AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Deva Holding AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dropsuite Ltd
AU:DSE
|
0.104x |
|
Kambi Group Plc
F:7KB
|
0.020x |
|
M Evo Global Acquisition Corp II Class A Ordinary Shares
NASDAQ:MEVO
|
N/A |
|
WCM Beteiligungs- und Grundbesitz-AG
F:WCMK
|
-0.005x |
|
DeFi Technologies Inc.
NEO:DEFI
|
-0.367x |
|
AzureWave Technologies Inc
TW:3694
|
0.076x |
|
Nano Dimension Ltd
F:2N5B
|
-0.040x |
|
Komax Holding AG
SW:KOMN
|
0.014x |
Annual Cash Flow Conversion Efficiency for Deva Holding AS (2005–2024)
The table below shows the annual cash flow conversion efficiency of Deva Holding AS from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Deva Holding AS market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL20.81 Billion ≈ $466.11 Million |
TL5.07 Billion ≈ $113.50 Million |
0.243x | -27.39% |
| 2023-12-31 | TL21.34 Billion ≈ $478.04 Million |
TL7.16 Billion ≈ $160.30 Million |
0.335x | +61.80% |
| 2022-12-31 | TL3.94 Billion ≈ $88.17 Million |
TL815.91 Million ≈ $18.27 Million |
0.207x | -54.69% |
| 2021-12-31 | TL2.73 Billion ≈ $61.10 Million |
TL1.25 Billion ≈ $27.95 Million |
0.457x | +15.74% |
| 2020-12-31 | TL1.63 Billion ≈ $36.61 Million |
TL645.98 Million ≈ $14.47 Million |
0.395x | -7.66% |
| 2019-12-31 | TL1.03 Billion ≈ $23.09 Million |
TL441.24 Million ≈ $9.88 Million |
0.428x | +143.91% |
| 2018-12-31 | TL746.41 Million ≈ $16.72 Million |
TL130.98 Million ≈ $2.93 Million |
0.175x | -4.20% |
| 2017-12-31 | TL605.09 Million ≈ $13.55 Million |
TL110.84 Million ≈ $2.48 Million |
0.183x | -49.88% |
| 2016-12-31 | TL512.85 Million ≈ $11.49 Million |
TL187.44 Million ≈ $4.20 Million |
0.365x | +86.96% |
| 2015-12-31 | TL453.11 Million ≈ $10.15 Million |
TL88.58 Million ≈ $1.98 Million |
0.195x | +56.38% |
| 2014-12-31 | TL411.91 Million ≈ $9.23 Million |
TL51.49 Million ≈ $1.15 Million |
0.125x | +0.69% |
| 2013-12-31 | TL403.05 Million ≈ $9.03 Million |
TL50.04 Million ≈ $1.12 Million |
0.124x | +618.95% |
| 2012-12-31 | TL378.63 Million ≈ $8.48 Million |
TL6.54 Million ≈ $146.43K |
0.017x | -67.04% |
| 2005-12-31 | TL114.50 Million ≈ $2.56 Million |
TL6.00 Million ≈ $134.34K |
0.052x | -- |
About Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more